SEC 13F Intelligence

Boxer Capital, LLC / CLYM

Boxer Capital, LLC’s Climb Bio Inc Position

Does Boxer Capital, LLC own Climb Bio Inc (CLYM)? Not currently — the last reported position was 2.60M shares worth $13M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$13M
Q3 2024
Shares
2.60M
% of Portfolio
+0.65%
Quarters Held
2
position exited

Position History CLYM

Reported value by quarter
Q2 ’24: $19MQ2 ’24Q3 ’24: $13MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20242.60M$13M+0.65%
Q2 20242.60M$19M+0.97%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of CLYM.